Testis cancer: genes, environment, hormones.

作者: Alberto Ferlin , Carlo Foresta

DOI: 10.3389/FENDO.2014.00172

关键词:

摘要: Testicular cancer (TC) is the most common in males aged 20-40 years, with a worldwide incidence of 7.5 per 100,000, but rates vary considerably between countries and ethnic groups there evidence also for an increasing last decades. About 95% all TCs are represented by testicular germ cell tumors (TGCTs), which include seminoma non-seminoma histological types. It generally assumed that development TGCT under endocrine control. In particular, unbalanced androgen/estrogen levels and/or activity believed to represent key events progression. Furthermore, recent has suggested genetic association variations genes involved hypothalamic-pituitary-testicular axis steroidogenic enzymes. This expands current knowledge on role contribution susceptibility, supports hypothesis hormone metabolism might change hormonal environment implicated carcinogenesis. Therefore, carcinogenesis important controversial area research TGCT, further attention given factors influencing hormone-related risk. The component general strong. fact, although environmental clearly contribute (and probably its some geographical areas), proportion susceptibility accounted effects estimated at 25%. high familial risks compared other types no more than two-fold: brothers individuals have 8- 12-fold increased risk disease, sons affected 4- 6-fold Despite this strong relative risk, early results from linkage studies identified limited relationship factors, suggesting genetically complex trait. However, recently, four genome-wide (GWAS) UK USA reported TGCTs six new loci (KITLG, SPRY4, BAK1, DMRT1, TERT, ATF7IP). strongest was found SNPs KITLG (ligand membrane-bound receptor tyrosine kinase KIT) gene greater 2.5-fold disease major allele, highest any date. These being now replicated researches these variations, frequently associated anomalies reproductive tract, such as cryptorchidism infertility. Finally, over past few decades, TCGT focused external causes acting mainly disrupters androgen oestrogen pathways, even during foetal testis. well known dysgenesis syndrome (TDS) hypothesis, proposed ten years ago, suggests disturbed fetal life may result one or disorders postnatally, named cryptorchidism, hypospadias, poor semen quality, TGCT. therefore considered clinical entity linked together epidemiological pathophysiological relations. genetics development, interactions disruptors another interesting research.

参考文章(16)
Peter A Kanetsky, Nandita Mitra, Saran Vardhanabhuti, Mingyao Li, David J Vaughn, Richard Letrero, Stephanie L Ciosek, David R Doody, Lauren M Smith, JoEllen Weaver, Anthony Albano, Chu Chen, Jacqueline R Starr, Daniel J Rader, Andrew K Godwin, Muredach P Reilly, Hakon Hakonarson, Stephen M Schwartz, Katherine L Nathanson, Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nature Genetics. ,vol. 41, pp. 811- 815 ,(2009) , 10.1038/NG.393
Lydia Ferguson, Alexander I. Agoulnik, Testicular cancer and cryptorchidism. Frontiers in Endocrinology. ,vol. 4, pp. 32- 32 ,(2013) , 10.3389/FENDO.2013.00032
Kimberly Banks, Ellenie Tuazon, Kiros Berhane, Chester J Koh, Roger E De Filippo, Andy Chang, Steve S Kim, Siamak Daneshmand, Carol Davis-Dao, Juan P Lewinger, Leslie Bernstein, Victoria K Cortessis, None, Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics Frontiers in Endocrinology. ,vol. 3, pp. 182- 182 ,(2013) , 10.3389/FENDO.2012.00182
Heather D. Mannuel, Nirupama Mitikiri, Maleha Khan, Arif Hussain, Testicular germ cell tumors: biology and clinical update. Current Opinion in Oncology. ,vol. 24, pp. 266- 271 ,(2012) , 10.1097/CCO.0B013E32835167FC
Andrea Garolla, Damiano Pizzol, Alessandro Bertoldo, Marco Ghezzi, Umberto Carraro, Alberto Ferlin, Carlo Foresta, Testicular cancer and HPV semen infection Frontiers in Endocrinology. ,vol. 3, pp. 172- 172 ,(2012) , 10.3389/FENDO.2012.00172
Elizabeth A Rapley, , Clare Turnbull, Ali Amin Al Olama, Emmanouil T Dermitzakis, Rachel Linger, Robert A Huddart, Anthony Renwick, Deborah Hughes, Sarah Hines, Sheila Seal, Jonathan Morrison, Jeremie Nsengimana, Panagiotis Deloukas, Nazneen Rahman, D Timothy Bishop, Douglas F Easton, Michael R Stratton, A genome-wide association study of testicular germ cell tumor. Nature Genetics. ,vol. 41, pp. 807- 810 ,(2009) , 10.1038/NG.394
John M. Hutson, Ruili Li, Bridget R. Southwell, Bodil L. Petersen, Jorgen Thorup, Dina Cortes, Germ cell development in the postnatal testis: the key to prevent malignancy in cryptorchidism? Frontiers in Endocrinology. ,vol. 3, pp. 176- 176 ,(2013) , 10.3389/FENDO.2012.00176
Aurelie Vega, Marine Baptissart, Françoise Caira, Florence Brugnon, Jean-Marc A. Lobaccaro, David H. Volle, Epigenetic: a molecular link between testicular cancer and environmental exposures Frontiers in Endocrinology. ,vol. 3, pp. 150- 150 ,(2012) , 10.3389/FENDO.2012.00150
Leon J. S. Brokken, Yvonne Lundberg-Giwercman, Ewa Rajpert-De Meyts, Jakob Eberhard, Olof Ståhl, Gabriella Cohn-Cedermark, Gedske Daugaard, Stefan Arver, Aleksander Giwercman, Association between polymorphisms in the aryl hydrocarbon receptor repressor gene and disseminated testicular germ cell cancer Frontiers in Endocrinology. ,vol. 4, pp. 4- 4 ,(2013) , 10.3389/FENDO.2013.00004
Chunkit Fung, David J. Vaughn, Nandita Mitra, Stephanie L. Ciosek, Saran Vardhanabhuti, Katherine L. Nathanson, Peter A. Kanetsky, Chemotherapy refractory testicular germ cell tumor is associated with a variant in Armadillo Repeat gene deleted in Velco-Cardio-Facial syndrome (ARVCF). Frontiers in Endocrinology. ,vol. 3, pp. 163- 163 ,(2012) , 10.3389/FENDO.2012.00163